Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
龙血竭栓治疗痔疮(风伤肠络证)的有效性和安全性的多中心、随机、双盲、剂量平行对照IIa期临床试验
[Translation] A multicenter, randomized, double-blind, dose-controlled phase IIa clinical trial on the efficacy and safety of Longxuejie suppository in the treatment of hemorrhoids (wind-damaged intestinal collateral syndrome)
初步评价龙血竭栓治疗痔疮(风伤肠络证)的安全性及有效性,探索龙血竭栓治疗痔疮的有效剂量
[Translation] To preliminarily evaluate the safety and effectiveness of Longxuejie suppositories in the treatment of hemorrhoids (wind-damaged intestinal collaterals syndrome) and to explore the effective dose of Longxuejie suppositories in the treatment of hemorrhoids
100 Clinical Results associated with Suzhou Ruihui Biomedical R & D Center Co., Ltd.
0 Patents (Medical) associated with Suzhou Ruihui Biomedical R & D Center Co., Ltd.
100 Deals associated with Suzhou Ruihui Biomedical R & D Center Co., Ltd.
100 Translational Medicine associated with Suzhou Ruihui Biomedical R & D Center Co., Ltd.